(Q46679252)

24 December 2017

title

Measuring SSRI occupancy of SERT using the novel tracer [123I]ADAM: a SPECT validation study (English)

1 reference

24 December 2017

author name string

Kjell Erlandsson

1

1 reference

24 December 2017

Tharani Sivananthan

2

1 reference

24 December 2017

Dominic Lui

3

1 reference

24 December 2017

Andrea Spezzi

4

1 reference

24 December 2017

Caroline E Townsend

5

1 reference

24 December 2017

Song Mu

6

1 reference

24 December 2017

Richard Lucas

7

1 reference

24 December 2017

Steven Warrington

8

1 reference

24 December 2017

Peter J Ell

9

1 reference

24 December 2017

publication date

26 August 2005

1 reference

24 December 2017

number of pages

8

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

24 December 2017

volume

32

1 reference

24 December 2017

issue

11

1 reference

24 December 2017

page(s)

1329-1336

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1007/s00259-005-1912-y

exact match

0 references

cites work

Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1912-Y

Reduced central serotonin transporters in alcoholism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1912-Y

Parkinson's disease: decreased density of 3H-imipramine and 3H-paroxetine binding sites in putamen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1912-Y

Presynaptic serotonergic dysfunction in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1912-Y

2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1912-Y

Biodistribution and radiation dosimetry of [123I]ADAM in healthy human subjects: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1912-Y

Imaging serotonin transporters with 123I-ADAM brain SPECT in healthy non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1912-Y

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1912-Y

Globally convergent algorithms for maximum a posteriori transmission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1912-Y

Simplified reference tissue model for PET receptor studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1912-Y

Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1912-Y

Modified regression model for the Logan plot

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1912-Y

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1912-Y

Effect of scatter correction on the compartmental measurement of striatal and extrastriatal dopamine D2 receptors using [123I]epidepride SPET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1912-Y

Limitations of bi-linear regression analysis for the determination of receptor occupancy with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1912-Y

Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1912-Y

Analysis of D2 dopamine receptor occupancy with quantitative SPET using the high-affinity ligand [123I]epidepride: resolving conflicting findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1912-Y

Altered serotonin transporter sites in Alzheimer's disease raphe and hippocampus.

21 January 2018

1 reference

12 December 2020

The pathogenesis and treatment of obsessive-compulsive disorder

1 reference

12 December 2020

The serotonin transporter and depression.

1 reference

12 December 2020

Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites

1 reference

12 December 2020

A practical method for position-dependent Compton-scatter correction in single photon emission CT

1 reference

12 December 2020

The role of in vivo neurotransmitter system imaging studies in understanding major depression

1 reference

12 December 2020

Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT.

1 reference

12 December 2020

Biodistribution and imaging with (123)I-ADAM: a serotonin transporter imaging agent

1 reference

12 December 2020

Quantification of serotonin transporters in nonhuman primates using [(123)I]ADAM and SPECT.

1 reference

12 December 2020

Characterization of the binding sites for 123I-ADAM and the relationship to the serotonin transporter in rat and mouse brains using quantitative autoradiography.

1 reference

12 December 2020

10.1007/S00259-005-1912-Y

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

16133377

1 reference

24 December 2017